The Ratings Game: Some ‘cheap’ biotech stocks that could be buyout targets, RBC says

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 25 January, 2016 by The TZ Newswire Staff

The Ratings Game: Some ‘cheap’ biotech stocks that could be buyout targets, RBC says

RBC Capital analysts pick out nine biotechnology stocks they cover that are trading below or just slightly above cash levels, which could make them buyout candidates for value investors.
read more

See also
- Next Article Earnings Outlook: What to expect from PayPal earnings
- Previous Article 3 Reasons Charles Schwab Stock Could Fall
Editorial Calender

January 2016

M T W T F S S

1 2 3

4 5 6 7 8 9 10

11 12 13 14 15 16 17

18 19 20 21 22 23 24

25 26 27 28 29 30 31

« Dec Feb »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar

The Traderszone Network

Editorial Archives

Published in TZ Latest News 25 January, 2016 by The TZ Newswire Staff

The Ratings Game: Some ‘cheap’ biotech stocks that could be buyout targets, RBC says

See also

Editorial Calender

Recent Tags